INTRODUCTION
A tight modulation of the insulin signal transduction is necessary to keep the balance between the maintenance of extracellular glucose homeostasis and intracellular energy consumption and storage. The binding of insulin to its receptor initiates and activates the insulin signal transduction cascade leading to a rapid increase in cellular glucose uptake (1) . The essential physiological balance between activation and termination of this cascade can be achieved by mechanisms whereby kinases modify elements of the signaling cascade leading to an initial enhancement of signal transduction and to a sequential attenuation. Such a critical key control mechanism of insulin action is the Ser-/Thr-phosphorylation of insulin receptor substrate (IRS)-1 (2) (3) (4) . Over the last decade several specific Serphosphorylation sites of IRS-1 have been identified. Reports investigating pathological insulin-resistance associated stimuli pointed to the involvement of Ser-phosphorylation of IRS-1 in the desensitization of insulin action (2-4), but there is increasing evidence that Serphosphorylation of IRS-1 may also serve as a tool to positively modulate insulin signaling under physiological conditions (5) (6) (7) (8) . This suggests that insulin action, besides an initial IRS-1 tyrosine phosphorylation, may lead to a rapid phosphorylation of serine residues of IRS-1 possibly necessary to contribute to a maximal stimulation of the insulin signal transduction. Furthermore, data describing one specific serine residue of IRS-1 either as a positive (9;10) or as a negative (11) (12) (13) regulatory phosphorylation site suggest a timeand stimulus-dependent function of serine phosphorylation of IRS-1. Recently, we developed a mass spectrometric strategy providing evidence for an in vitro phosphorylation of Ser 318 of rat IRS-1 (Ser 323 in human IRS-1) by PKC-ζ (14) . The phosphorylation of Ser 318 has been suggested to be involved in the negative regulation of insulin signal transduction in baby hamster kidney cells which were manipulated to overexpress the insulin receptor, IRS-1 and PKC-ζ (15) . But, up to now the most important function of insulin-induced PKC-ζ activation is the stimulation of GLUT4 translocation and glucose transport, i.e. it serves as a kinase positively transmitting the insulin signal (16) (17) (18) . Because glucose uptake and storage in muscle is rate limiting in glucose disposal (19;20) and in states of insulin resistance the skeletal muscle contributes significantly to decreased glucose uptake (19) , we aimed to investigate the regulation and function of Ser 318 phosphorylation in skeletal muscle. Skeletal muscle cells from different origins including humans were studied. For the investigation of the effect of Ser 318 on glucose uptake the wellcharacterized L6 GLUT4myc cells which sensitively respond to insulin (21) were stably transfected with wild type or Ala 318 or Glu 318 mutated IRS-1. We found that 1) Ser 318 is rapidly phosphorylated in various skeletal muscle cells after insulin stimulation and in muscle tissue of insulin-treated mice, but not by insulin resistance-inducing pathological stimuli, 2) the rapid phosphorylation of Ser 318 exerts an enhancing effect on insulin signal transduction and glucose uptake, and is also necessary for the subsequent attenuation of insulin signaling and action as assessed by Ser 473 phosphorylation of Akt/PKB and glucose uptake, 3) the insulin-stimulated phosphorylation in muscle cells is mediated by atypical PKC-ζ. Human primary skeletal muscle cells were grown from satellite cells obtained from percutaneous needle biopsies performed on the lateral portion of quadriceps femoris (vastus lateralis) muscle as recently described (23) . The donors were normal weight healthy Caucasian subjects. The study was approved by the local ethical committee and informed written consent had been obtained from all subjects prior to the biopsy. All experiments were performed on the first-pass of subcultured cells that were plated at ~5 x 10 4 cells in 60 cm 2 dishes in a 1:1 mixture of α-MEM and Ham's F-12 supplemented with 20 % fetal calf serum (FCS), 1 % chicken embryo extract and 0.2 % antibiotic antimycotic solution (growth medium) as described (23) . When myoblasts reached 80 -90 % confluence, the cells were fused for 5 days in α-MEM containing 5.5 mM glucose with 2 % FCS and 0.2 % antibiotic antimycotic solution (fusion medium). Stimulation of the myotubes with insulin was performed in fusion medium. C2C12 myoblasts were cultured in α-MEMcontaining 25 mM glucose, 10% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. 1.0 x 10 5 cells/well of a 6-well plate were transfected using the Ca 3 (PO 4 ) 2 -DNA-co-precipitation-method (24) . After incubation overnight at 37°C in 5% CO 2 ( 40 h after transfection), the cells were starved in α-MEM (5.5 mM glucose) without FCS for 3 h, then stimulated with insulin, as indicated. Cells were lysed with 200 µl of lysis buffer/well (50 mM Tris pH 7.6, 150 mM NaCl, 1% Triton X-100, containing protease and phosphatase inhibitors). Total protein (400 µg) was used for immunoprecipitation.
EXPERIMENTAL PROCEDURES
Immunoprecipitated proteins or 20 µg protein of the total extracts were separated by SDS-PAGE (7.5 %) and Western blot analysis was performed as described (22) . L6 myoblasts were cultured in α-MEM containing 5.5 mM glucose, 10 % FCS, 100 U/ml penicillin and 100 µg/ml streptomycin as described (21) . For differentiation, 0.5 x 10 5 cells/well of a 12-well plate or 2.0 x 10 5 /well of a 6-well plate were seeded in differentiation medium (α-MEM containing 5.5 mM glucose, 2 % FCS, 100 U/ml penicillin and 100 µg/ml streptomycin). Myotubes were used 7-8 days after cell seeding. In vivo insulin treatment of mice -Ten-week old male C57Bl/6 mice were obtained from "The Jackson Laboratory" (USA) and studied after 2 weeks of acclimatization. They were maintained on a normal light/dark cycle and kept on a regular diet. For in vivo stimulation mice were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg b.w.) and xylazine (10 mg/kg b.w.), and a total of 5 IU insulin were injected into the inferior Vena cava. Controls received a comparable amount of diluent. Skeletal muscle tissue was removed at the indicated time points and homogenized at 4°C by Potter homogenization in lysis buffer (50 mM TRIS pH 7.6, 150 mM NaCl, 1% Triton-X-100 containing a phosphatase and protease inhibitor mixture) (25) . Homogenates were allowed to solubilize for 30 min on ice and clarified by centrifugation at 12000 g for 20 minutes. The supernatant was then collected and protein content determined by the Bradford method. All procedures were approved by the local Animal Care and Use Committee.
2-Deoxy-glucose uptake -
L6 Glut4myc myoblasts stably transfected with wild type or Ala 318 or Glu 318 of IRS-1 were seeded in 12-well plates and were differentiated to myotubes. Cells were serum-starved for three hours in α-MEM prior to experiment. After stimulation with 100 nM insulin, cells were washed with HEPES buffered saline (HBS; containing 140 mM NaCl, 20 mM HEPES-Na, pH 7.4, 5 mM KCl, 2.5 mM MgSO 4 , 1 mM CaCl 2 ) and 300 µl/well of 2-deoxy-glucose mix (HBS containing 0.25 µCi/ml 3 H-2-deoxyglucose and 10 µM 2-deoxy-glucose) was added. After incubation at 37 °C, 5 % CO 2 for 7 min, cells were washed three times with 0.9 % NaCl and lysed with 250 µl of lysis buffer. Total amounts of cell lysates were counted by liquid scintillation counting. Protein content of lysates generally varied < 10 %. Statistical analysis -Results presented are derived from at least three independent experiments. Means ± SEM were calculated and groups of data were compared using student´s t test. A p-value < 0.05 was considered to be statistically significant.
RESULTS

Phosphorylation of Ser
318
by different stimuli in skeletal muscle cells. Skeletal muscle is a major target tissue of peripheral insulin action via IRS-1 and consequently of impaired insulin action (insulin resistance). Therefore, we investigated the effects of different substances known to affect insulin signal transduction on the phosphorylation of Ser 318 using human myotubes obtained from biopsies from quadriceps femoris and L6 myotubes. Interestingly, substances known to impair insulin signaling like elevated glucose and TNF-α (Fig. 1A ), adrenalin and lipopolysaccharides (Fig. 1B) , as well as fatty acids (data not shown) did not stimulate the phosphorylation of Ser 318 in myotubes. Remarkably, TNF-α and the Jun-kinase activator anisomycin, which are well known strong inducers of the phosphorylation of the closely adjacent and inhibitory Ser 307 in IRS-1 (26), exerted no effect on Ser 318 (Fig. 1A) . By contrast, the physiologically relevant stimuli insulin ( Fig. 1A and B) and IGF-1 (Fig. 1B) led to an increase in the phosphorylation of Ser 318 . Furthermore, the phorbolester 12-Otetradecanoyl 13-phorbol acetate (TPA), a pharmacological activator of classical and novel PKC-isoforms (22), strongly increased the phosphorylation of Ser 318 in human and L6 myotubes ( (2-4;6-8) . Therefore, the time-and dose-response curves of the insulin-stimulated phosphorylation of Ser 318 were studied. L6 myotubes were treated with various insulin concentrations for 10 min resulting in a clear increase of the Ser 318 phosphorylation with 10 nM of insulin which could not be further enhanced using 100 nM (data not shown). Consequently, the phosphorylation kinetic was studied using 10 nM insulin for various time intervals. In the same extracts we monitored the tyrosine phosphorylation of IRS-1. Insulin stimulated a rapid phosphorylation of both the IRS-1 tyrosine residues and of Ser 318 in L6 myotubes within 5 min (Fig. 2) . When the phosphorylation of Ser 318 reached its maximum after 30 and 60 min, the tyrosine phosphorylation was reduced, well in line with the described attenuation of insulin signal transduction after prolonged insulin stimulation. In the ongoing insulin action at 180 and 360 min the Ser 318 phosphorylation was clearly decreased, while the level of IRS-1 tyrosine phosphorylation recured up to the intensity at 5 and 10 min. The IRS-1 protein was essentially unchanged during the 6-hour experiment (Fig. 2) phosphorylation of IRS-1 suggests a physiological function in insulin signaling. This is supported by the lack of enhanced Ser 318 phosphorylation by insulin resistanceassociated factors. Therefore, we studied the influence of p-Ser 318 of IRS-1 on the insulininduced time-dependent phosphorylation of the serine/threonine kinase PKB/Akt, a key molecule in downstream signaling (e.g. regulating insulin effects on glucose uptake (27) ), in C2C12 skeletal muscle cells. Cells were transiently transfected with either wild type or mutated Ala 318 IRS-1 and stimulated for various time points with 10 nM insulin (Fig. 4A) . The increase in Ser 473 phosphorylation of PKB/Akt was less pronounced in Ala 318 IRS-1 expressing cells after 10 min of insulin stimulation compared to cells expressing wild type IRS-1, but in contrast to wild type cells no decrease was found after 60 min of insulin stimulation (Fig.  4 B, n = 6). Of note, IRS-1 protein levels were not affected by the Ala 318 mutation (Fig. 4A ). These data are well in line with the our previously reported findings in BHK cells (15) phosphorylation, but we detected no effect (Fig. 6 A) . Additionally, pretreatment of the cells with Calphostin C (500 and 1000 nM) failed to reduce the insulin-stimulated phosphorylation of Ser 318 (data not shown). By contrast, using 30 min preincubation with LY 294002 or wortmannin, two relatively specific, but structurally different inhibitors of PI 3-kinase, completely prevented the Ser 318 phosphorylation by 30 min of insulin stimulation (Fig. 6 A) . These data suggest that atypical PKC-isoforms may be involved in insulin-stimulated phosphorylation of Ser 318 on IRS-1 in skeletal muscle. To prove the role of PKC-ζ, we preincubated the myotubes with increasing concentrations of the cellpermeable, myristoylated peptide with a sequence based on the endogenous PKC-ζ pseudosubstrate region (myr-SIRRGARRWRKL-NH 2 ), i.e. an inhibitor of PKC-ζ (38;39). The insulin-induced phosphorylation of Ser 318 was completely blocked in the presence of 10 µM PKC-ζ pseudosubstrate (Fig. 6 B) , a concentration within the lower range of those reported to inhibit PKC-ζ in other cellular systems (38) . Noteworthy, basal phosphorylation of Ser 318 was slightly inhibited by 10 µM myristoylated PKC-ζ pseudosubstrate (data not shown), suggesting the presence of significant basal PKC-ζ activity in unstimulated myotubes as previously noted (40) . To assess the contribution of PKC-ζ-mediated phosphorylation of Ser 318 to glucose transport, we compared the inhibitory effects of the PKC-ζ pseudosubstrate peptide on glucose transport in L6 GLUT4myc cell lines transfected with either wild type or Glu 318 IRS-1 (Fig. 6 C) . The insulin-stimulated glucose uptake was significantly reduced by 5 and 10 µM PKC-ζ pseudosubstrate peptide in both wild type and Glu 318 transfected cells, possibly caused by the previously shown essential role of PKC-ζ in the insulin-stimulated glucose uptake in L6 cells (16) . Taken together, our results suggest that the rapid phosphorylation of Ser 318 in skeletal muscle cells is mediated by PKC-ζ, whereas cPKCs and nPKCs are not involved and that this effect is PI 3-kinase dependent. Consequence of the phosphorylation of Ser 318 on the interaction of PKC-ζ and IRS-1. To verify that the activation of PKC-ζ by insulin occurs parallel to the observed phosphorylation of Ser 318 in our experimental system, the time course of the phosphorylation of Thr 410 of PKC-ζ was analyzed. We observed a rapid insulin-induced phosphorylation of Thr 410 of PKC-ζ, well in line with the time course of the short time insulin-stimulated Ser 318 phosphorylation in the L6 myotubes (Fig. 7 A) . Furthermore, we found a rapid insulin-stimulated interaction of PKC-ζ and IRS-1 by immunoprecipitation of PKC-ζ and immunoblotting for IRS-1 (Fig. 7 B) . The interaction of endogenous IRS-1 and PKC-ζ is strongly increased after 5 min of insulinstimulation followed by a decrease after 10 and 60 min to a level near the basal state (Fig. 7 B) . (Fig. 7 C) . In contrast, in Glu 318 IRS-1 overexpressing C2C12 cells the IRS-1 co-immunoprecipitation was strongly reduced. The observed signals possibly represent the endogenous IRS-1 protein. IRS-1 expression levels were similar under all conditions (data not shown). Together, these data may indicate that after phosphorylation of Ser 318 by PKC-ζ, the association of IRS-1 and PKC-ζ is largely reduced. Thus, PKC-ζ is responsible for the initial phosphorylation of Ser 318 .
DISCUSSION
The physiological balance between the maintenance of extracellular glucose homeostasis and intracellular energy consumption and storage in skeletal muscle is regulated by the activation and physiological attenuation of insulin-stimulated signal transduction. One key mechanism in this context is the Ser-/Thr-phosphorylation of IRS-1. Here we provide for the first time evidence in a physiologically relevant target tissue of insulin action, that the phosphorylation of Ser 318 1) is part of the insulin-induced initial phosphorylation pattern of IRS-1 in skeletal muscle, 2) is required for an enhanced induction of insulin action, and 3) subsequently serves as a prerequisite for attenuation/termination of insulin-stimulated signal transduction, i.e. leading to a decrease in glucose uptake. Upon investigation of the molecular mechanism we found that 4) the phosphorylation of Ser 318 is mediated by PKC-ζ, 5) the observed insulin-induced interaction of PKC-ζ and IRS-1 is transient and 6) the subsequent and rapid (10 min 318 . Accordingly, the phosphorylation at position 318 serves also as a prerequisite for physiological attenuation/termination of insulin-stimulated signal transduction. A previous study has shown that insulin stimulates the association of IRS-1 and PKC-ζ in freshly isolated rat adipose cells after 5 min (37) . In our study, we investigated the molecular mechanism of the PKC-ζ-mediated Ser 318 phosphorylation in skeletal muscle cells and observed a parallel time course of PKC-ζ activation, PKC-ζ/IRS-1 interaction and Ser 318 phosphorylation within 5 min of insulin action. However, the interaction was transient being reduced near baseline levels after 10 min. To study if Ser 318 phosphorylation is causally involved we simulated the phosphorylation of Ser 318 by Glu 318 mutation, which resulted in a markedly reduced interaction while the wild type and the Ala 318 mutant of IRS-1 strongly interacted with PKC-ζ. This result indicates that the introduction of a negative charge at position 318 leads to a substantial reduction in PKC-ζ/IRS-1 interaction. Since the interaction of PKC-ζ and Ala 318 IRS-1 is unaffected we conclude that the negative charge rather than the amino acid substitution is the cause for this effect. Together these data suggest that the product of the PKC-ζ-mediated reaction i.e. Ser 318 phosphorylated IRS-1 prevents the binding of PKC-ζ to the substrate thus limiting the further reaction of PKC-ζ at this molecule. Our observation of a sequentially different function of one phosphorylation site in insulin action could also help to understand the apparently inconsistent data about the positive and negative function of one specific IRS-1 phosphorylation site, as have been reported for Ser 789 (9;11;12) or Ser 302 (10;13). Ser 789 was first described as a positive acting AMPactivated protein kinase-dependent site in C2C12 myotubes leading to an improved insulin signal transduction (9) . But, more recently a striking increase of Ser 789 -phosphorylated IRS-1 in livers of insulinresistant rodent models (11), as well as impaired IRS-1 action mediated by saltinducible kinase-2 phosphorylation of Ser 789 was described (12) . The phosphorylation of Ser 302 in response to agents which induce insulin resistance (e.g. hyperinsulinemia, anisomycin) seems to inhibit the IRS-1 functions (13). However, recently also positive effects on insulin action have been identified for the Ser 302 phosphorylation of IRS-1 (10). Hence, these reports on one serine phosphorylation site of IRS-1 including the results of the present study reveal, that the same site may exert different function in insulin action, depending on the time-point of phosphorylation and the presence of environmental factors, which differently regulate the phosphorylation of this site and other sites. Although all classes of protein kinase C (PKC) isoforms phosphorylate the Ser 318 residue in vitro (unpublished observation) and TPA as a pharmacological stimulus of all classical and novel PKC-isoforms led to the phosphorylation of Ser 318 in myotubes, here we show that the insulin-stimulated phosphorylation in muscle cells is mediated by PKC-ζ. The PKC-ζ-mediated phosphorylation of Ser 318 is well in line with the initial positive influence of this phosphorylation on insulin action, since insulin-stimulated, PI 3-kinase-dependent activation of PKC-ζ is an important key element in insulin-stimulated glucose uptake (16) (17) (18) . Noteworthy, the groups of Zick (36) and Quon (37) reported on a dual function of PKC-ζ on insulin signal transduction. They showed, besides the known positive effect, that PKC-ζ-mediated serine phosphorylation of IRS-1 is involved in the attenuation of insulin action. Additionally, we have recently shown in baby hamster kidney cells which were manipulated to overexpress the insulin receptor, IRS-1 and PKC-ζ that Ser 318 may be involved in this negative feedback loop after 60 min of insulin stimulation (15) . Thus the question raises if PKC-ζ is the kinase involved in the attenuation of the insulin signaling after 60 min of insulin stimulation. In the present study we have shown that the PKC-ζ-mediated phosphorylation of Ser 318 is not per se inhibitory, but is necessary to trigger the attenuation of the insulin-stimulated signal in skeletal muscle cells. Ser 318 might be a priming site that is required for the phosphorylation of other sites. Therefore we hypothesize, that the assumed sequential changes in the phosphopattern of IRS-1 attenuating the insulinstimulated signal are mediated by other PKCs or other kinases. In this context it is interesting to note, that the mutation of seven serine residues to alanine in IRS-1 (Ser , and Ser 408 ), six of which are putative PKC phosphorylation sites, partially prevented the attenuation of the insulin signal after 60 min stimulation with high insulin concentrations (100 nM) (41) . In conclusion, since previous studies investigating specific IRS-1 serine phosphorylation sites showed either a stimulating or an attenuating action so far, our findings provide new perspectives on phosphoserine dependent modulation of the insulin signal transduction. The present results suggest that Ser 318 of IRS-1 is a rapidly phosphorylated serine residue upon insulin stimulation in skeletal muscle, an important target tissue of insulin action. The physiological function of the PKC-ζ-mediated Ser 318 phosphorylation at the early time point is an enhancement of insulin-dependent glucose uptake, but the phosphorylation of this site is also necessary for the physiological attenuation/termination of the insulin-stimulated signal transduction. Thus, insulin-stimulated phosphorylation of Ser 318 by PKC-ζ in skeletal muscle may be necessary to maintain the physiological balance of cellular energy homeostasis.
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* We thank Roman Werner for his excellent technical assistance. This work was supported in part by grants of the German Diabetes Society (DDG) and the German Research Council (KFO-114). 1 The abbreviations used are: DOG, deoxyglucose; GLUT, glucose transporter, IRS, insulin receptor substrate; PI 3-kinase, phosphatidylinositol 3-kinase; PKB, protein kinase B; PKC, protein kinase C; p-Ser, phospho-serine; TPA, 12-O-tetradecanoyl 13-phorbol acetate. Immunoblots with the phospho-site specific Ser 318 antibody and reprobe of the same blot with the polyclonal IRS-1 antibody are shown. Ser 318 phosphorylation intensity was quantified based on scanning densitometry of immunoblots normalized for IRS-1 protein (n=6). (C) Effects of PKC-ζ-pseudosubstrate (60 min preincubation) on the insulin-stimulated 2-deoxyglucose (2-DOG) uptake in skeletal muscle cells. The L6 myotubes were stimulated for 20 min with 100 nM insulin and 2-DOG uptake was determined as described in the Method section. The relative changes in the insulin-stimulated 2-DOG uptake are shown (mean ± SE, n = 3). * = significant differences in glucose uptake of PKC-ζ-pseudosubstrate treated vs. untreated L6 cells. 
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